Amid increasing economic tensions with the United States, China recently announced that it would ban Illumina, a U.S.-based company and the ...

Gene mutations in acute myeloid leukemia (AML) cells can guide treatment options, and machine learning can rapidly guess the ...

The San Diego company also lowered its financial guidance for 2025 in response to China’s import restrictions.

The Global Synthetic Biology Market is estimated to be valued at USD 13.83 billion in 2023 and is projected to expand at a robust Compound Annual Growth Rate (CAGR) of 17.30% over the forecast period ...

Recent advancements in the realm of genetic diagnostics have led to the development of a groundbreaking RNA sequencing test, marking a significant leap forward in the diagnosis of Mendelian diseases.

Adding to Illumina’s headwinds, Roche has introduced its new SBX technology, which is expected to directly compete with Illumina’s next-generation sequencing (NGS ... as Beijing banned the import of ...

Investing.com -- Chinese stocks related to genetic sequencing experienced gains after Beijing implemented a ban on the import of machines from Illumina (NASDAQ:ILMN), a US-based company. This move is ...

China banned the import of Illumina Inc. gene-sequencing machines as part of a wave of retaliatory measures against fresh US tariffs on all Chinese goods, deepening the US company’s woes in one of its ...

Investing.com -- Chinese stocks related to genetic sequencing experienced gains after Beijing implemented a ban on the import of machines from Illumina (NASDAQ:ILMN), a US-based company.